Title
a. Authorize the Chief Executive Officer for Natividad Medical Center (NMC) or a designee to execute a retroactive nonstandard service agreement with Boston Scientific Corporation for LT Pulse 100 Laser equipment support and services at NMC for a maximum County obligation of $48,600 for the term of December 3, 2025 through December 2, 2029.
b. Approve the NMC’s Chief Executive Officer’s recommendation to accept non-standard contract provisions within the agreement.
Report
RECOMMENDATION:
It is recommended the Board of Supervisors:
a. Authorize the Chief Executive Officer for Natividad Medical Center (NMC) or a designee to execute a retroactive nonstandard service agreement with Boston Scientific Corporation for LT Pulse 100 Laser equipment support and services at NMC for a maximum County obligation of $48,600 for the term of December 3, 2025 through December 2, 2029.
b. Approve the NMC’s Chief Executive Officer’s recommendation to accept non-standard contract provisions within the agreement.
SUMMARY:
This service agreement will cover our LT Pulse 100 Laser. This service agreement will cover:
Priority equipment services and support.
One preventive maintenance (PM) every 12 months.
Coverage of 100% for all field service travel, labor, rates and fees.
Software: All Technical Service Updates (TSUs).
Coverage of 100% for all parts and components.
Two business days response time
Standard 2 business days shipping
Excludes: Replacement of disposable items and accessories, including but not limited to catheters, cables, manuals, safety glasses, outer panels, blast shields, fibers, fiber pole base and hand pieces, loaner, software upgrade, hardware upgrade, and costs associated with preparation & installation of the Pulse™ 100H Holmium Laser Therapy System, and any other third party equipment not purchased from BSC. Accidental/physical damage is not covered, including damage to the system chassis. Loss of the equipment is not covered.
DISCUSSION
The Lumenis Pulse 100H Holmium Laser System is a 100-watt, high-powered surgical laser primarily used for urologic procedures, specifically stone dusting/fragmentation and Holmium Laser Enucleation of the Prostate (HoLEP) to treat Benign Prostatic Hyperplasia (BPH). It is designed for soft tissue incision, excision, and coagulation across multiple specialties, including gynecology and general surgery.
OTHER AGENCY INVOLVEMENT:
The Office of County Counsel has reviewed and approved this agreement as to form, and the Auditor-Controller has reviewed and approved as to payment provisions. The agreement has also been reviewed and approved by NMC’s Finance Committee and by its Board of Trustees on April 3, 2026.
FINANCING:
The cost for this agreement is $48,600 which is included in the FY 2025-26 Adopted Budget. There is no impact on the General Fund with this action.
BOARD OF SUPERVISORS STRATEGIC PLAN GOALS SECTION:
The use of this laser will provide essential Urologic Care for patients who suffer from urologic stones and enlarged prostrate.
X Well-Being and Quality of Life
__ Sustainable Infrastructure for Present and Future
__ Safe and Resilient Communities
__Diverse and Thriving Economy
__ Administrative
Prepared by: Wally Sayles, Director of Surgical Services, 772-7771
Approved by: Charles R. Harris, Chief Executive Officer, 783-2553
Attachment(s):
Board Report
Boston Scientific Corporation Original Agreement
Attachments on file with the Clerk of the Board